(Q51373468)

4 April 2018

title

The plasma level and gene expression of resistin in polycystic ovary syndrome. (English)

1 reference

4 April 2018

polycystic ovary syndrome

main subject

1 reference

1 reference

Jing Zhang

1

1 reference

4 April 2018

Lingling Zhou

series ordinal

2

1 reference

4 April 2018

Liulin Tang

series ordinal

3

1 reference

4 April 2018

Liangzhi Xu

series ordinal

4

1 reference

4 April 2018

publication date

11 May 2011

1 reference

4 April 2018

Gynecological Endocrinology

published in

1 reference

4 April 2018

volume

27

1 reference

4 April 2018

issue

12

1 reference

4 April 2018

page(s)

982-987

1 reference

4 April 2018

Polycystic Ovary Syndrome

cites work

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.569794

Current concepts in the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.569794

Increased C-reactive protein levels in the polycystic ovary syndrome: a marker of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.569794

Plasma interleukin 6 levels are elevated in polycystic ovary syndrome independently of obesity or sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.569794

IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.569794

Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.569794

The hormone resistin links obesity to diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.569794

The current biology of resistin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.569794

Regulation of fasted blood glucose by resistin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.569794

Resistin: yet another adipokine tells us that men are not mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.569794

Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.569794

Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.569794

Serum resistin level in essential hypertension patients with different glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.569794

Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.569794

Plasma resistin, leptin and adiponectin levels in non-diabetic and diabetic obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.569794

Associations of resistin with inflammation and insulin resistance in patients with type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.569794

Plasma resistin levels in patients with type 1 and type 2 diabetes mellitus and in healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.569794

Serum adiponectin and resistin concentrations in patients with restrictive and binge/purge form of anorexia nervosa and bulimia nervosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.569794

Resistin is not associated with insulin sensitivity or the metabolic syndrome in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.569794

Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.569794

Evidence for altered adipocyte function in polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.569794

Resistin stimulation of 17alpha-hydroxylase activity in ovarian theca cells in vitro: relevance to polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.569794

Serum resistin and adiponectin levels in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.569794

Endothelial dysfunction in PCOS: role of obesity and adipose hormones.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.569794

Serum and follicular resistin levels in women with polycystic ovarian syndrome during IVF-stimulated cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.569794

Serum resistin levels in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.569794

Serum and adipocyte resistin in polycystic ovary syndrome with insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.569794

Adipocyte resistin mRNA levels are down-regulated by laparoscopic ovarian electrocautery in both obese and lean women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.569794

Serum resistin and adiponectin levels in young non-obese women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.569794

Serum ghrelin, leptin and resistin levels in adolescent girls with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.569794

Adiponectin and resistin serum levels in women with polycystic ovary syndrome during oral glucose tolerance test: a significant reciprocal correlation between adiponectin and resistin independent of insulin resistance indices.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.569794

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.569794

Abnormal glucose tolerance in Chinese women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.569794

Endothelial dysfunction in vivo is related to monocyte resistin mRNA expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.569794

Study of Resistin gene expression in peripheral blood mononuclear cell and its gene polymorphism in a small range population

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.569794

Peripheral mononuclear cell resistin mRNA expression is increased in type 2 diabetic women.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.569794

Resistin / Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.569794

Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.569794

Increased expression of the macrophage markers and of 11beta-HSD-1 in subcutaneous adipose tissue, but not in cultured monocyte-derived macrophages, is associated with liver fat in human obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.569794

10.3109/09513590.2011.569794

21 January 2018

Identifiers

DOI

1 reference

4 April 2018

PubMed ID

21557697

1 reference

4 April 2018